- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-002069-31.
Displaying page 1 of 1.
EudraCT Number: 2014-002069-31 | Sponsor Protocol Number: PCYC-1130-CA | Start Date*: 2014-11-11 | ||||||||||||||||
Sponsor Name:Pharmacyclics LLC | ||||||||||||||||||
Full Title: A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton’s Tyrosine Kinase Inhibitor Ibrutinib in Combination with Obinutuzumab versus Chlorambucil in Combination with Obinutuzumab in Sub... | ||||||||||||||||||
Medical condition: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) IT (Completed) CZ (Completed) AT (Completed) BE (Completed) ES (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
